Temozolomide and Short-term memory loss - from FDA reports


Summary

Short-term memory loss is found among people who take Temozolomide, especially for people who are male, 50-59 old , have been taking the drug for < 1 month, also take medication Keppra, and have Glioblastoma multiforme . We study 4,752 people who have side effects while taking Temozolomide from FDA. Among them, 42 have Short-term memory loss. Find out below who they are, when they have Short-term memory loss and more.

What to expect?

If you take Temozolomide and have Short-term memory loss, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Temozolomide and have Short-term memory loss

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Temozolomide

Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. (latest outcomes from Temozolomide 4,789 users)

Short-term Memory Loss

Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 105,191 Short-term memory loss patients).

On Feb, 06, 2017

4,752 people reported to have side effects when taking Temozolomide.
Among them, 42 people (0.88%) have Short-term Memory Loss


Number of reports submitted per year:

Could Temozolomide cause Short-term memory loss?

Time on Temozolomide when people have Short-term Memory Loss *:

  • < 1 month: 61.54 %
  • 1 - 6 months: 23.08 %
  • 6 - 12 months: 15.38 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Short-term Memory Loss when taking Temozolomide *:

  • female: 36.59 %
  • male: 63.41 %

Age of people who have Short-term Memory Loss when taking Temozolomide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.67 %
  • 30-39: 3.33 %
  • 40-49: 3.33 %
  • 50-59: 46.67 %
  • 60+: 40.0 %

Top conditions involved for these people *:

  • Glioblastoma Multiforme (10 people, 23.81%)
  • Glioblastoma (5 people, 11.90%)
  • Brain Neoplasm Malignant (4 people, 9.52%)
  • Glioma (2 people, 4.76%)
  • Blood Corticotrophin Increased (2 people, 4.76%)

Top co-used drugs for these people *:

  • Keppra (7 people, 16.67%)
  • Nexium (6 people, 14.29%)
  • Decadron (6 people, 14.29%)
  • Dilantin (5 people, 11.90%)
  • Avastin (4 people, 9.52%)

Top other side effects for these people *:

  • Weakness (13 people, 30.95%)
  • Confusional State (13 people, 30.95%)
  • Headache (12 people, 28.57%)
  • Cognitive Disorder (10 people, 23.81%)
  • Fatigue (7 people, 16.67%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Short-term memory loss when taking Temozolomide?

Browse all side effects of Temozolomide

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Short-term memory loss

Short-term memory loss

Could your condition cause Short-term memory loss

Short-term memory loss

Related studies

Can you answer these questions?

More questions for: Temozolomide, Short-term memory loss

You may be interested in these reviews

More reviews for: Temozolomide, Short-term memory loss